Efficacy and safety of paclitide versus paclitaxel for locally advanced and/or metastatic breast cancer: an open-label, multi-center, phase IIb, randomized controlled trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Paclitide (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Jun 2011 to 30 Nov 2012 as reported by Chinese Clinical Trial Register record.
- 03 Feb 2011 New trial record